Published in J Drug Target on June 01, 2004
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res (2006) 2.86
Integrin targeted delivery of chemotherapeutics. Theranostics (2011) 1.42
Integrin Targeted MR Imaging. Theranostics (2011) 1.00
From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker. Bioconjug Chem (2013) 0.95
Nanomedical engineering: shaping future nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.89
Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates. Mol Pharm (2011) 0.85
Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm (2013) 0.84
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev (2016) 0.84
High efficiency diffusion molecular retention tumor targeting. PLoS One (2013) 0.83
(68)Ga-Labeling of RGD peptides and biodistribution. Int J Clin Exp Med (2012) 0.83
Triggering cell detachment from patterned electrode arrays by programmed subcellular release. Nat Protoc (2010) 0.83
Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery. Mol Pharm (2010) 0.81
Small molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imaging. Biomaterials (2012) 0.77
Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure. J Pharm Sci (2014) 0.75
Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras. Protoplasma (2012) 0.75
Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model. Pharm Res (2017) 0.75
Self-organization of Nucleic Acids in Lipid Constructs. Curr Opin Colloid Interface Sci (2016) 0.75
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm (2001) 1.22
The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials (2010) 1.19
Ophthalmoscopic abnormalities in adults with falciparum malaria. QJM (1998) 1.17
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv (2007) 1.12
The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol (2012) 1.10
Prognostic significance of eye changes in cerebral malaria. J Assoc Physicians India (2000) 1.08
Oral delivery of anticancer drugs: challenges and opportunities. J Control Release (2013) 1.06
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm (2003) 1.03
Development and characterization of 99mTc-timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS PharmSciTech (2009) 0.99
Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm (2000) 0.97
Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. FASEB J (2013) 0.96
Carbon nanotubes in cancer theragnosis. Nanomedicine (Lond) (2010) 0.95
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm (2005) 0.93
Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways. J Biol Chem (2013) 0.92
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys (2011) 0.92
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm (2004) 0.92
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv (2011) 0.91
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine (2007) 0.90
Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst (2011) 0.89
The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials (2010) 0.89
Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury. Mol Cell Biol (2012) 0.89
Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin. J Drug Target (2008) 0.89
Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des (2009) 0.89
Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharm Sci (2001) 0.88
Tunable elastin-like polypeptide hollow sphere as a high payload and controlled delivery gene depot. J Control Release (2011) 0.88
Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology (2013) 0.87
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target (2006) 0.87
Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev Ind Pharm (1998) 0.87
Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol (2006) 0.87
pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie (2002) 0.86
Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol (2004) 0.86
Green and rapid synthesis of anticancerous silver nanoparticles by Saccharomyces boulardii and insight into mechanism of nanoparticle synthesis. Biomed Res Int (2013) 0.86
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies. Pharmazie (2000) 0.84
Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy. ACS Nano (2009) 0.84
Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model. Mol Pharm (2011) 0.84
TWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity. Skelet Muscle (2013) 0.84
The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol (2000) 0.83
Polysaccharide coated liposomes for oral immunization--development and characterization. Int J Pharm (2000) 0.83
Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein. Mol Pharm (2012) 0.83
Intranuclear drug delivery and effective in vivo cancer therapy via estradiol-PEG-appended multiwalled carbon nanotubes. Mol Pharm (2013) 0.83
Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio. Bioconjug Chem (2014) 0.83
Primary extramedullary solitary plasmacytoma of conjunctiva--a case report. Indian J Ophthalmol (1985) 0.82
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol Pharm (2009) 0.82
Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol (2005) 0.82
Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. Mol Pharm (2013) 0.82
Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. Int J Pharm (2005) 0.82
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Curr Cancer Drug Targets (2010) 0.82
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett (2005) 0.82
Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. J Drug Target (2010) 0.81
A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles. Vaccine (2012) 0.81
Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials (2011) 0.81
Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm (2005) 0.81
Hyaluronate tethered, "smart" multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem (2012) 0.80
Functionalization density dependent toxicity of oxidized multiwalled carbon nanotubes in a murine macrophage cell line. Chem Res Toxicol (2012) 0.80
Localized rifampicin albumin microspheres. J Microencapsul (1991) 0.80
Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study. Pharm Acta Helv (2000) 0.80
Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul (1996) 0.80
Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharm Res (2001) 0.80
Proliposomes of indomethacin for oral administration. J Microencapsul (1991) 0.80
Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery. J Drug Target (2010) 0.80
In situ gel systems as 'smart' carriers for sustained ocular drug delivery. Expert Opin Drug Deliv (2012) 0.80
Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Nanomedicine (2007) 0.80
Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting. Curr Mol Med (2013) 0.80
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine (2011) 0.80
Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm (2004) 0.79
Topical liposome system bearing local anaesthetic lignocaine: preparation and evaluation. J Microencapsul (1994) 0.79
Implication of gut immunology in the design of oral vaccines. Curr Mol Med (2010) 0.79
Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 0.79
Synthetic peptides: a modern approach to vaccination. Indian J Exp Biol (1998) 0.79
Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization. Pharmazie (2001) 0.79
Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res (2006) 0.79
Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis. Methods Find Exp Clin Pharmacol (2009) 0.79
Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J Pharm Pharmacol (2006) 0.78
Retracted "Clickable", trifunctional magnetite nanoparticles and their chemoselective biofunctionalization. Bioconjug Chem (2011) 0.78
Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery. Curr Med Chem (2007) 0.78
Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm (2007) 0.78
Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocomposites. J Biomed Nanotechnol (2009) 0.78
Targeted intracellular delivery of therapeutics: an overview. Pharmazie (2007) 0.78
Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. Int J Pharm (2006) 0.78
Surface chemistry dependent "switch" regulates the trafficking and therapeutic performance of drug-loaded carbon nanotubes. Bioconjug Chem (2013) 0.78
Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharm Res (2013) 0.78
Organogel-based system for transdermal delivery of propranolol. J Microencapsul (1994) 0.78
Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci (1996) 0.77
Passive vectoring of a colloidal carrier system for sodium stibogluconate: preparation, characterization and performance evaluation. J Drug Target (1993) 0.77
Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis. J Drug Target (2010) 0.77
Hepatitis B surface protein docked vesicular carrier for site specific delivery to liver. J Drug Target (2005) 0.77
Mannosylated liposomes for bio-film targeting. Int J Pharm (2006) 0.77
Steroid receptors as molecular targets for cancer diagnosis and therapy. Crit Rev Ther Drug Carrier Syst (2009) 0.77
Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes. Eur J Pharm Sci (2008) 0.77